Objective 1.6 million people are killed worldwide each year due to ovarian, endometrial, bladder and prostate cancers. The key to making treatment breakthrough is early diagnosis.PROTBIOFLUID is a new network for developing innovative early diagnostic techniques and for spreading this knowledge through the medical community by a systematic exchange of staff to create high impact benefits to patients and transform the way these cancers are managed.Our overall science objective is to study biofluids in cancer patients in order to determine specific proteomic profiles to lay the foundation for the development of a simple to use diagnostic tool that will become ubiquitous in the medium-to-long-term. Our objectives to create this impact are:1. Establish new methods for proteomic identification of biomarkers in biofluids for the early diagnosis and prognosis of cancer2. Evaluate molecular markers and therapeutic targets of metastasis through the use of preclinical animal modelsCurrently the know-how to reach these objectives exists but the field is highly fragmented. Therefore, we need this IRSES project as a catalyst for a focused network to create the critical mass to solve very pressing treatment problems. We have selected leading research partners with established relations of trust and reciprocity and who bring the correct combinations of complementary expertise. To effect the interlinking of research lines we have designed a systematic exchange of both very senior staff and those at earlier phases of their career. Through this mechanism we will achieve both high level knowledge exchanges as well as knowledge transfer through teaching and ‘hands on’ experience of best practice.At the end of the PROTBIOFLUID we will have agreed a framework for joint programming between partner institutions. This first nucleus of teams will be the core of a growing network of excellence that will transform both what and how things are done in the treatment of these deadly cancers Fields of science medical and health sciencesclinical medicineoncologyprostate cancernatural sciencesbiological sciencesbiochemistrybiomoleculesproteinsproteomicsnatural scienceschemical sciencescatalysis Programme(s) FP7-PEOPLE - Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) Topic(s) FP7-PEOPLE-2010-IRSES - Marie Curie Action "International Research Staff Exchange Scheme" Call for proposal FP7-PEOPLE-2010-IRSES See other projects for this call Funding Scheme MC-IRSES - International research staff exchange scheme (IRSES) Coordinator FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA EU contribution € 224 700,00 Address PASSEIG VALL D HEBRON 119-129 EDIFICIO DE RECERCA 08035 Barcelona Spain See on map Region Este Cataluña Barcelona Activity type Research Organisations Administrative Contact Ramon Cosialls Ferrer (Mr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data Participants (1) Sort alphabetically Sort by EU Contribution Expand all Collapse all LUXEMBOURG INSTITUTE OF HEALTH Luxembourg EU contribution € 130 200,00 Address 1A RUE RUE THOMAS EDISON 1445 Strassen See on map Region Luxembourg Luxembourg Luxembourg Activity type Research Organisations Administrative Contact Jean Claude Schmidt (Dr.) Links Contact the organisation Opens in new window Website Opens in new window Total cost No data
